Estimations of worldwide prevalence of chronic hepatitis B virus infection: a systematic review of data published between 1965 and 2013.

doi:10.1016/S0140-6736(15)61412-X

Journal ArticleDOI

Estimations of worldwide prevalence of chronic hepatitis B virus infection: a systematic review of data published between 1965 and 2013.

Aparna Schweitzer, +4 more

- 17 Oct 2015 -

The Lancet

- Vol. 386, Iss: 10003, pp 1546-1555

Chats0

TLDR

This first global assessment of country-level population prevalence of chronic HBV infection found a wide variation between countries and highlights the need for continued prevention and control strategies and the collection of reliable epidemiologic data using standardised methodology.

About:

This article is published in The Lancet.The article was published on 2015-10-17. It has received 2130 citations till now. The article focuses on the topics: HBsAg & Hepatitis B virus.

Citations

PDF

Open Access

More filters

Journal ArticleDOI

Temporal trend of hepatitis B surface mutations in the post-immunization period: 9 years of surveillance (2005-2013) in eastern China.

Bingyu Yan, +12 more

- 27 Jul 2017 -

Scientific Reports

TL;DR: The data showed that there was no increase in the frequency of HBV “α” mutations over time during the post-immunization period, however, long-term vaccination might enhance the change ofHBV mutational pattern, and G145 mutation was becoming dominant.

...read moreread less

Journal ArticleDOI

How to improve access to therapy in hepatitis B patients.

Miroslava Subic, +2 more

- 10 Feb 2018 -

Liver International

TL;DR: The new WHO 2016 Global Health Sector Strategy on viral hepatitis targets testing and treatment, suggesting that important but strong actions are needed from advocacy groups, scientific societies and funding agencies to foster awareness and access to cure.

...read moreread less

Journal ArticleDOI

Performance of the Xpert HBV Viral Load assay versus the Aptima Quant assay for quantifying hepatitis B virus DNA.

Florence Abravanel, +10 more

- 01 Feb 2020 -

Diagnostic Microbiology and Infectious D...

TL;DR: The Xpert HBV Viral load assay is reliable enough for quantifying HBV DNA in clinical practice and correlated with the Aptima Quant HBV assays, with similar patient profiles with trends in the same direction.

...read moreread less

Journal ArticleDOI

Therapeutic potential of bicyclol in liver diseases: Lessons from a synthetic drug based on herbal derivative in traditional Chinese medicine.

Tianming Zhao, +11 more

- 01 Feb 2021 -

International Immunopharmacology

TL;DR: Wang et al. as discussed by the authors provided the first summary of pharmacological activities, pharmacokinetic characteristics and toxicity of bicyclol, and discuss future research perspectives, which indicated that bicyclol has a wide spectrum of pharmacologic properties, including anti-viral, anti-inflammatory, immuno-regulatory, antioxidative, antisteatotic, antifibrotic, antitumor, cell death regulatory effects and modulation of heat shock proteins.

...read moreread less

Journal ArticleDOI

Hepatitis B treatment eligibility in West Africa: Uncertainties and need for prospective cohort studies.

Antoine Jaquet, +10 more

- 01 Aug 2017 -

Liver International

TL;DR: While universal screening of hepatitis B virus is recommended in high burden countries, little is known about the proportion of HBV‐infected persons in need of antiviral therapy in these settings.

...read moreread less

Collapse

References

PDF

Open Access

More filters

Journal Article

R: A language and environment for statistical computing.

R Core Team

- 01 Jan 2014 -

MSOR connections

TL;DR: Copyright (©) 1999–2012 R Foundation for Statistical Computing; permission is granted to make and distribute verbatim copies of this manual provided the copyright notice and permission notice are preserved on all copies.

...read moreread less

Journal ArticleDOI

Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement

David Moher, +4 more

- 21 Jul 2009 -

PLOS Medicine

TL;DR: Moher et al. as mentioned in this paper introduce PRISMA, an update of the QUOROM guidelines for reporting systematic reviews and meta-analyses, which is used in this paper.

...read moreread less

Journal Article

Preferred reporting items for systematic reviews and meta-analyses: the PRISMA Statement.

David Moher, +4 more

- 21 Jul 2009 -

Open Medicine

TL;DR: The QUOROM Statement (QUality Of Reporting Of Meta-analyses) as mentioned in this paper was developed to address the suboptimal reporting of systematic reviews and meta-analysis of randomized controlled trials.

...read moreread less

Journal ArticleDOI

Preferred reporting items for systematic reviews and meta-analyses: The PRISMA statement

David Moher, +4 more

- 01 Jan 2010 -

International Journal of Surgery

TL;DR: A structured summary is provided including, as applicable, background, objectives, data sources, study eligibility criteria, participants, interventions, study appraisal and synthesis methods, results, limitations, conclusions and implications of key findings.

...read moreread less

Journal ArticleDOI

Global, regional, and national age-sex specific all-cause and cause-specific mortality for 240 causes of death, 1990-2013: A systematic analysis for the Global Burden of Disease Study 2013

Mohsen Naghavi, +731 more

- 10 Jan 2015 -

The Lancet

TL;DR: In the Global Burden of Disease Study 2013 (GBD 2013) as discussed by the authors, the authors used the GBD 2010 methods with some refinements to improve accuracy applied to an updated database of vital registration, survey, and census data.

...read moreread less